These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 28440297)

  • 1. Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis.
    Hou YC; Hu Q; Huang J; Fang JY; Xiong H
    Sci Rep; 2017 Apr; 7():46650. PubMed ID: 28440297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
    Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
    Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
    Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
    Shen C; Shi Y; Liang T; Su P
    Dig Endosc; 2017 May; 29(3):281-290. PubMed ID: 28112441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis.
    Rustagi T; Njei B
    Pancreas; 2015 Aug; 44(6):859-67. PubMed ID: 26168316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis.
    Liu L; Li C; Huang Y; Jin H
    J Gastrointest Surg; 2019 Oct; 23(10):1991-2001. PubMed ID: 30251071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
    Wan J; Ren Y; Zhu Z; Xia L; Lu N
    BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal nonsteroidal anti-inflammatory drugs and pancreatic stents in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: A network meta-analysis.
    Shou-Xin Y; Shuai H; Fan-Guo K; Xing-Yuan D; Jia-Guo H; Tao P; Lin Q; Yan-Sheng S; Ting-Ting Y; Jing Z; Fang L; Hao-Liang Q; Man L
    Medicine (Baltimore); 2020 Oct; 99(42):e22672. PubMed ID: 33080710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Sun HL; Han B; Zhai HP; Cheng XH; Ma K
    Surgeon; 2014 Jun; 12(3):141-7. PubMed ID: 24332479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: A Network Meta-Analysis.
    Yang J; Wang W; Liu C; Zhao Y; Ren M; He S
    J Clin Gastroenterol; 2020 Apr; 54(4):305-313. PubMed ID: 32011404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
    Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.
    Patai Á; Solymosi N; Mohácsi L; Patai ÁV
    Gastrointest Endosc; 2017 Jun; 85(6):1144-1156.e1. PubMed ID: 28167118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis.
    Li X; Tao LP; Wang CH
    World J Gastroenterol; 2014 Sep; 20(34):12322-9. PubMed ID: 25232268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
    Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
    Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis.
    Du F; Zhang Y; Yang X; Zhang L; Yuan W; Fan H; Ren L
    J Gastrointest Surg; 2022 Sep; 26(9):1982-1997. PubMed ID: 35680777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis.
    Puig I; Calvet X; Baylina M; Isava Á; Sort P; Llaó J; Porta F; Vida F
    PLoS One; 2014; 9(3):e92922. PubMed ID: 24675922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.